Average Co-Inventor Count = 5.82
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Institut National De La Sante Et De La Recherche Medicale (6 from 1,744 patents)
2. Université De Lille 2 Droit Et Santé (3 from 13 patents)
3. Alzprotect (3 from 4 patents)
4. Sanofi (1 from 1,455 patents)
5. Innogenetics N.v. (1 from 80 patents)
6. Centre Hospitalier Regional Et Universitaire De Lille (chru) (1 from 9 patents)
7. Universite Du Droit Et De La Santa-lille II (1 from 1 patent)
8. Universite De Lille 2 Droit Et Saute (1 from 1 patent)
9. Centre National De La Recherche Scientifique (5,089 patents)
10. Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris (77 patents)
11. Université De Lille (55 patents)
12. Centre Hospitalier Régional Universitaire De Lille (24 patents)
13. Centre Hospitalier Régional Et Universitaire De Lille (1 patent)
14. Inserm (0 patent)
15. Universite Du Droit Et De La Sante - Lille II (0 patent)
7 patents:
1. 10807958 - 1,4-bis(3-aminopropyl)piperazine derivative and its use
2. 10772884 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same
3. 10537569 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same
4. 10017476 - 1,4-bis(3-aminopropyl)piperazine derivative and its use
5. 9562018 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same
6. 9044478 - Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
7. 8343493 - Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs